Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 7 studies | 59% ± 19% | |
epithelial cell | 7 studies | 42% ± 11% | |
progenitor cell | 5 studies | 40% ± 19% | |
transit amplifying cell | 4 studies | 25% ± 5% | |
brush cell | 4 studies | 39% ± 11% | |
squamous epithelial cell | 3 studies | 32% ± 13% | |
goblet cell | 3 studies | 22% ± 4% | |
intestinal crypt stem cell | 3 studies | 34% ± 7% | |
glutamatergic neuron | 3 studies | 36% ± 10% | |
acinar cell | 3 studies | 83% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 132774.27 | 328 / 328 | 87% | 205.68 | 154 / 178 |
intestine | 51% | 1330.96 | 488 / 966 | 97% | 171.50 | 512 / 527 |
stomach | 31% | 181.70 | 113 / 359 | 95% | 139.35 | 273 / 286 |
esophagus | 39% | 1013.34 | 562 / 1445 | 62% | 67.36 | 113 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.15 | 1 / 1 |
skin | 85% | 1380.85 | 1536 / 1809 | 7% | 5.31 | 32 / 472 |
brain | 77% | 760.04 | 2038 / 2642 | 11% | 2.26 | 77 / 705 |
adrenal gland | 8% | 42.17 | 20 / 258 | 57% | 57.29 | 132 / 230 |
liver | 31% | 116.86 | 69 / 226 | 31% | 13.43 | 125 / 406 |
bladder | 14% | 34.95 | 3 / 21 | 45% | 57.22 | 228 / 504 |
lung | 1% | 3.11 | 5 / 578 | 23% | 17.56 | 266 / 1155 |
uterus | 1% | 30.71 | 2 / 170 | 19% | 9.98 | 88 / 459 |
tonsil | 0% | 0 | 0 / 0 | 20% | 8.61 | 9 / 45 |
kidney | 10% | 31.24 | 9 / 89 | 2% | 0.83 | 14 / 901 |
breast | 3% | 32.62 | 13 / 459 | 2% | 0.30 | 18 / 1118 |
ovary | 1% | 1.54 | 1 / 180 | 2% | 0.57 | 9 / 430 |
prostate | 2% | 8.69 | 4 / 245 | 1% | 0.12 | 4 / 502 |
adipose | 2% | 56.86 | 25 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 35.35 | 15 / 1335 | 0% | 0 | 0 / 0 |
heart | 1% | 4.18 | 8 / 861 | 0% | 0 | 0 / 0 |
spleen | 1% | 3.03 | 2 / 241 | 0% | 0 | 0 / 0 |
thymus | 0% | 2.44 | 3 / 653 | 0% | 0.04 | 1 / 605 |
muscle | 0% | 1.37 | 4 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.66 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019730 | Biological process | antimicrobial humoral response |
GO_0043542 | Biological process | endothelial cell migration |
GO_0006508 | Biological process | proteolysis |
GO_0031638 | Biological process | zymogen activation |
GO_0007586 | Biological process | digestion |
GO_0005615 | Cellular component | extracellular space |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0008236 | Molecular function | serine-type peptidase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | PRSS3 |
Protein name | PRSS3 protein Trypsin-3 (EC 3.4.21.4) (Brain trypsinogen) (Mesotrypsin) (Mesotrypsinogen) (Serine protease 3) (Serine protease 4) (Trypsin III) (Trypsin IV) Serine protease 3 |
Synonyms | TRY4 TRY3 PRSS4 |
Description | FUNCTION: Digestive protease that cleaves proteins preferentially after an Arg residue and has proteolytic activity toward Kunitz-type trypsin inhibitors. . |
Accessions | A1A508 ENST00000429677.8 [P35030-5] ENST00000361005.10 P35030 A0A7P0MP65 ENST00000379405.4 [P35030-3] Q8N2U3 A0A7P0MNE9 ENST00000342836.9 |